🔎 Trials Near Me

Akèy › Hypertension artérielle › Tennessee

Etid klinik pou Hypertension artérielle nan Tennessee

19 etid pou Hypertension artérielle ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Alliance for Multispecialty Research, LLC-Knoxville-69693, Knoxville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  • Chattanooga Research & Medicine CHARM, Chattanooga
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07511361

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • New Phase Research and Development, Knoxville
  • Clinical Research Associates Inc, Nashville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Chattanooga
  • Research Site, Knoxville
  • Research Site, Knoxville
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Chattanooga
  • Clinical Trial Site, Chattanooga
  • Clinical Trial Site, Knoxville
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Global Paradise System US Post Approval Study

  • Ascension Saint Thomas, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • Clinical Neuroscience Solutions Inc, Memphis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

  • Community DPC, Cleveland
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06843577

2-HOBA in Systemic Lupus Erythematosus

  • Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou May 22, 2026 · NCT07225543

Metabolic Effects of Angiotensin-(1-7)

  • Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou May 22, 2026 · NCT02646475

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

  • Vanderbit University Medical Center, Nashville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05955339

Exercise Testing After Preeclampsia

  • Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Apr 14, 2026 · NCT06741436

CPAP for the Treatment of Supine Hypertension

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Apr 7, 2026 · NCT05489575

Sympathetic Mechanisms in Obesity-Crossover Design

  • Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT05312892

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

  • University of Tennessee Medical Center, Knoxville
  • University of Tennessee Health Science Center/Regional One Health, Memphis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 29, 2026 · NCT06374277

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jan 16, 2026 · NCT03042988

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Nov 6, 2025 · NCT03312556

Gut Microbiota in Metabolic Surgery

  • Vanderbilt_University MC, Nashville
Ap rekriteEtid obsèvasyon
Laj 21 a 65 · Tout sèks · Mizajou Nov 4, 2025 · NCT05000996

Team Lifestyle Immersion Hypertension Control Project

  • Meharry Medical College, Nashville
Ap rekriteVolontè an sante akeyi
Laj 30 a 80 · Tout sèks · Mizajou Oct 1, 2025 · NCT07201948

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.